MAIA Biotechnology, Inc. (MAIA) stock
MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
$1.30+0.05 (+4.00%)
Close on Nov 18, 2026Market cap $79.07MP/E –Yield –
MAIA Biotechnology cash
Cash and short-term investments held at the end of each period.
MAIA Biotechnology's cash was $0 at Jun 30, 2026. For fiscal 2025 it was $0. The highest annual figure on record is $10.95M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2023 | Dec 31, 2023 | $7.15M | -34.7% |
| FY2022 | Dec 31, 2022 | $10.95M | +3.6% |
| FY2021 | Dec 31, 2021 | $10.57M | +1493.8% |
| FY2020 | Dec 31, 2020 | $663.46K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $0 | -100.0% |
| Q1 FY2024 | Mar 31, 2024 | $8.27M | +9.0% |
| Q4 FY2023 | Dec 31, 2023 | $7.15M | -34.7% |
| Q3 FY2023 | Sep 30, 2023 | $6.10M | -56.6% |
| Q2 FY2023 | Jun 30, 2023 | $9.15M | +12.2% |
| Q1 FY2023 | Mar 31, 2023 | $7.59M | -26.3% |
| Q4 FY2022 | Dec 31, 2022 | $10.95M | +3.6% |
| Q3 FY2022 | Sep 30, 2022 | $14.06M | +28.4% |
| Q2 FY2022 | Jun 30, 2022 | $8.15M | +20.2% |
| Q1 FY2022 | Mar 31, 2022 | $10.29M | +1451.5% |
| Q4 FY2021 | Dec 31, 2021 | $10.57M | – |
| Q3 FY2021 | Sep 30, 2021 | $10.95M | – |
| Q2 FY2021 | Jun 30, 2021 | $6.78M | – |
| Q4 FY2020 | Dec 31, 2020 | $663.46K | – |
See a number that looks wrong?